Business
10x Genomics, Inc. (TXG) Q4 2025 Earnings Call Transcript
Company Participants
Cassie Corneau – Manager of Investor Relations & Strategic Finance
Serge Saxonov – Co-Founder, CEO & Director
Adam Taich – CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer
Conference Call Participants
Tycho Peterson – Jefferies LLC, Research Division
Douglas Schenkel – Wolfe Research, LLC
Puneet Souda – Leerink Partners LLC, Research Division
Daniel Arias – Stifel, Nicolaus & Company, Incorporated, Research Division
Kyle Mikson – Canaccord Genuity Corp., Research Division
Daniel Brennan – TD Cowen, Research Division
Patrick Donnelly – Citigroup Inc. Exchange Research
Mason Carrico – Stephens Inc., Research Division
Subhalaxmi Nambi – Guggenheim Securities, LLC, Research Division
Lu Li – UBS Investment Bank, Research Division
Michael Ryskin – BofA Securities, Research Division
Salem Salem – Barclays Bank PLC, Research Division
Casey Woodring – JPMorgan Chase & Co, Research Division
Matthew Larew – William Blair & Company L.L.C., Research Division
Presentation
Operator
Thank you for standing by. My name is Karli, and I will be your conference operator today. At this time, I would like to welcome everyone to the 10x Genomics Fourth Quarter and Full Year 2025 Earnings Call. [Operator Instructions]
I would now like to turn the call over to Cassie Corneau, Senior Director, Investor Relations and Strategic Finance. Please go ahead.
Cassie Corneau
Manager of Investor Relations & Strategic Finance
Thank you, and good afternoon, everyone. Earlier today, 10x Genomics released financial results for the fourth quarter and full year ended December 31, 2025. If you have not received this news release or would like to be added to the company’s distribution list, please send an e-mail to investors@10xgenomics.com.
An archived webcast of this call will be available on the Investor tab of the company’s website, 10xgenomics.com, for at least 45 days following this call.
Before we begin, I’d like to remind you